"Carolinas Pain Institute is dedicated to the diagnosis and treatment of chronic, acute, and cancer pain. We offer the latest advances in pharmacology, physiotherapy, and cognitive and interventional therapy, access to national clinical trials through the Center for Clinical Research, and support and educational resources through our partnership with PainPathways Magazine. Medication alone may not be enough to manage certain kinds of pain. Some medicines are more effective in fighting pain when they are combined with other methods of treatment. In some cases, the patient's pain condition may respond to treatment instead of medication."

During the past decade, Carolinas Pain Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolinas Pain Institute" #1 sponsor was "Celgene Corporation" with 2 trials, followed by "Prostrakan Pharmaceuticals" with 2 trials sponsored, "Carolinas Pain Institute" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored and "Mesoblast, Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolinas Pain Institute" #1 collaborator was "BioDelivery Sciences International" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Carolinas Pain Institute" are "Cancer" (2 trials), "Pain" (2 trials), "Back Pain Lower Back Chronic" (1 trials), "Chronic Pain" (1 trials) and "Complex Regional Pain Syndrome, Type I" (1 trials). Many other conditions were trialed in "Carolinas Pain Institute" in a lesser frequency.

Most popular intervention types in "Carolinas Pain Institute" are "Drug" (8 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "EN3267" (2 trials), "Buprenorphine Buccal Film [Belbuca]" (1 trials), "CMM + Axon Therapy" (1 trials) and "Lenalidomide (CC-5013)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolinas Pain Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Carolinas Pain Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Carolinas Pain Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carolinas Pain Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".